Yüklüyor......
Peroxisome Proliferator-Activated Receptor γ Controls Ingestive Behavior, Agouti-Related Protein, and Neuropeptide Y mRNA in the Arcuate Hypothalamus
Peroxisome proliferator-activated receptor γ (PPARγ) is clinically targeted for type II diabetes treatment; however, rosiglitazone (ROSI), a PPARγ agonist, increases food intake and body/fat mass as side-effects. Mechanisms for these effects and the role of PPARγ in feeding are not understood. There...
Kaydedildi:
| Yayımlandı: | J Neurosci |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Society for Neuroscience
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363385/ https://ncbi.nlm.nih.gov/pubmed/25788674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2129-14.2015 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|